Latest Breaking News On - Consortium of multiple sclerosis centers - Page 12 : comparemela.com

Sanofi MS Drug Shines in Phase 2, Paving Way for a Pivotal Test Next Year

Frexalimab, a Sanofi drug candidate with roots at Dartmouth’s medical school, has met the main goal of its Phase 2 test. The encouraging data for this program come as different experimental Sanofi MS drug nears its one-year anniversary under FDA clinical hold.

United statesPrincipia biopharmaErik wallstrGeisel school of medicine at dartmouthConsortium of multiple sclerosis centersMultiple sclerosis centersNew hampshire based immunextGeisel schoolWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock health

Immunic to Participate in Scientific and Investor Conferences in June

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

United statesPaula schwartzJessica breuAurora hallEdna kaplanRobertj foxExchange commissionPrnewswire immunic incInternational conventionImmunic incMellen centerNeurologic instituteRx communications groupConsortium of multiple sclerosis centersMultiple sclerosis centersAnnual meeting

EQS-News: Immunic to Participate in Scientific and Investor Conferences in June

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in June 30.05.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Investor Conferences in June NEW YORK,.

United statesAurora hallEdna kaplanPaula schwartzRobertj foxJessica breuDistribution servicesNeurologic instituteExchange commissionConsortium of multiple sclerosis centersImmunic incMellen centerRx communications groupInternational conventionInvestor conferencesMultiple sclerosis centers

EQS-News: Immunic, Inc : Immunic to Participate in Scientific and Investor Conferences in June

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in June 30.05.2023 / 12:30 CET/CEST The issuer is solely responsible

United statesRobertj foxEdna kaplanAurora hallJessica breuPaula schwartzInternational conventionNeurologic instituteExchange commissionConsortium of multiple sclerosis centersImmunic incDistribution servicesMellen centerRx communications groupInvestor conferencesMultiple sclerosis centers

Small cap snapshot: Soma Gold, Thor Explorations, Revolve Renewable Power, PyroGenesis, Numinus

Small cap snapshot: Soma Gold, Thor Explorations, Revolve Renewable Power, PyroGenesis, Numinus
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRobertj foxSteve hansonRobert kaulLithium incRakovina therapeutics incInternational conventionMetals corpRogers creek property to cascade copper corpImmunic incKillum wynn creative incMaxim groupConsortium of multiple sclerosis centersLiam greenlawWynn creative